Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi says FDA accepts filing for new diabetes drug Toujeo
Yahoo/Reuters
Tuesday, July 8, 2014 - 7:45am
tags:
FDA, diabetes, Toujeo, Sanofi
Purdue’s Abuse-Resistant Pill Gets FDA Priority Review
Bloomberg
Tuesday, July 8, 2014 - 7:43am
tags:
Purdue Pharma, FDA, abuse-resistant painkillers, Zogenix, Zohydro
China says GSK-linked trial being handled according to law
Reuters
Tuesday, July 8, 2014 - 7:41am
tags:
China, GSK
Study paves the way for a blood test to predict Alzheimer's
Yahoo/Reuters
Tuesday, July 8, 2014 - 7:40am
tags:
diagnostics, Alzheimer's disease
Ackman proposes new slate of Allergan directors amid takeover war
Marketwatch
Monday, July 7, 2014 - 7:32pm
tags:
Bill Ackman, Allergan, M&A, Valeant Pharmaceuticals
Testosterone elevating drugs free of heart attack risk, study says
Fierce Pharma
Monday, July 7, 2014 - 7:31pm
tags:
testosterone, AbbVie, Androgel, heart attacks, Eli Lilly, Pfizer
3 Small-Cap Biotechs That Institutions Are Loving
Yahoo/Benzinga
Monday, July 7, 2014 - 7:30pm
tags:
Infinity Pharmaceuticals, Vanda, Lexicon Pharmaceuticals
Merck Says It Regrets Strong-Arming Italian Researcher
Forbes
Monday, July 7, 2014 - 7:26pm
tags:
Merck
Is Bristol-Myers Squibb Co. Destined for Greatness?
Motley Fool
Monday, July 7, 2014 - 7:23pm
tags:
Bristol-Myers Squibb
Omega Pharma Exploring Sale of More Than $4 Billion
Bloomberg
Monday, July 7, 2014 - 3:33pm
tags:
Omega Pharma, M&A, OTC, consumer health
Arena CEO Dumps Stock as Share Price, Investor Confidence Slide
TheStreet.com
Monday, July 7, 2014 - 11:33am
tags:
Arena Pharmaceuticals, Pharma CEOs, Jack Lief, Belviq
What Money? Docs Don’t Have to Disclose Pharma Payments Down Under
WSJ Online
Monday, July 7, 2014 - 11:30am
tags:
physician payments, Physician Payment Sunshine Act, Australia
J&J hands over $25M milestone for daratumumab progress
Fierce Biotech
Monday, July 7, 2014 - 11:25am
tags:
JNJ, daratumumab, Genmab
Where's the U.K. outrage over AbbVie's pursuit of Shire?
Fierce Biotech
Monday, July 7, 2014 - 11:05am
tags:
UK, M&A, Shire, AbbVie, AstraZeneca, Pfizer
Headache devices avoid heavy regulation in new FDA rule
Mass Device
Monday, July 7, 2014 - 10:57am
tags:
headache, FDA, devices, STX-Med, Cefaly
RegeneRx’s Strategic Partner G-treeBNT Preparing for Phase III Dry Eye Trials in Asia with RGN-259
Yahoo
Monday, July 7, 2014 - 10:55am
tags:
RegeneRx, G-treeBNT, dry eye disease, RGN-259, Asia
Gilead Sciences Has A Realistic Path To $100
Seeking Alpha
Monday, July 7, 2014 - 10:53am
tags:
Gilead Sciences, hepatitis C, Sovaldi, HIV, Stribild
AbbVie Will Make Another Attempt To Buy Shire PLC
Motley Fool
Monday, July 7, 2014 - 10:37am
tags:
AbbVie, Shire, M&A
Endo, BioDelivery painkiller effective in late-stage study
Yahoo/Reuters
Monday, July 7, 2014 - 8:47am
tags:
Endo Health Solutions, painkillers, BioDelivery Sciences, BEMA Buprenorphine
FDA's Looming Decision On A Generic To Teva's Copaxone Reveals Drug Approval Woes
Forbes
Monday, July 7, 2014 - 7:49am
tags:
Teva Pharmaceutical, Copaxone, generics, MS, multiple sclerosis, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.